Manufacturing

Agnes Shanley is senior editor of Pharmaceutical Technology.

Articles

Shipping biopharmaceuticals in single-use containers requires a thorough understanding of the distribution cycle and potential transportation risks.

Best Practices for Shipping Single-Use Systems

Magali Barbaroux is R&D vice-president at Sartorius Stedim Biotech FMT, Aubagne, France.

Jean-Marc Cappia is vice-president of marketing for fluid management technology at Sartorius Stedim Biotech FMT, Aubagne, France.

Increased use of single-use systems has led to a need to redefine safe, stable and integral systems for shipping biopharmaceuticals around the world. This article provides qualification data under international ASTM D4169 norms.

An Integrated Approach to Shipping Liquid in Single-Use Systems

The company will showcase its drum-filling technology among other products and services at the upcoming ACHEMA 2018 event in Frankfurt, Germany.

Harro Höfliger to Showcase Drum-Filling Technology at ACHEMA 2018

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

INTERPHEX presents advances in pharmaceutical container filling, robotic handling, and serialization. 

New Equipment and Software Meet Needs for Fill/Finish, Serialization, and Data Traceability

This workshop, to be held in Sheffield, United Kingdom, on June 7, 2018, will provide an introduction to the use of glass as primary pharmaceutical packaging.

Glass Technology Services to Hold Pharmaceutical Glassware Workshop in June 2018

The company will build a high-volume manufacturing facility for their glass packaging product in Durham County, NC.

Corning Invests in New Glass Packaging Facility

New filling and inspection machines and new containers and closures for injectable drugs will be on display at INTERPHEX 2018.

Parenteral Packaging Innovations

Keystone Folding Box has added a new line of secondary packaging systems for injectable pharmaceutical products.

Secondary Packaging Solutions for Injectables

Helsinn will acquire the global rights to Valchlor/Ledaga (mechlorethamine/chlormethine), a topical skin-cancer drug, from Actelion Pharmaceuticals.

Helsinn to Acquire Rights to Skin Cancer Drug

Revisions to chapters on glass containers and elastomeric closures were canceled following review of comments.

Packaging and Distribution